Increased resistance to multiple drugs by introduction of the Enterobacter cloacae romA gene into OmpF porin-deficient mutants of Escherichia coli K-12.
AUTOR(ES)
Komatsu, T
RESUMO
Introduction of the romA gene cloned from Enterobacter cloacae into Escherichia coli K-12 resulted in almost complete inhibition of OmpF expression and a concomitant increase in resistance to quinolones, beta-lactams, chloramphenicol, and tetracyclines. In addition, the romA gene reduced the susceptibility to these multiple drugs even in the OmpF porin-deficient mutants of E. coli K-12. Results indicate the presence of romA-sensitive penetration pathway(s) for these multiple drugs other than the OmpF porin in E. coli.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=245346Documentos Relacionados
- Assembly of LamB and OmpF in deep rough lipopolysaccharide mutants of Escherichia coli K-12.
- cis-acting sites required for osmoregulation of ompF expression in Escherichia coli K-12.
- OmpF assembly mutants of Escherichia coli K-12: isolation, characterization, and suppressor analysis.
- Regulation of outer membrane porin protein synthesis in Escherichia coli K-12: ompF regulates the expression of ompC.
- In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.
